Nemes Rush Group’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-3
| Closed | -$2 | – | 772 |
|
|
2024
Q4 | $2 | Hold |
3
| – | – | ﹤0.01% | 726 |
|
|
2024
Q3 | $27 | Hold |
3
| – | – | ﹤0.01% | 603 |
|
|
2024
Q2 | $23 | Hold |
3
| – | – | ﹤0.01% | 599 |
|
|
2024
Q1 | $27 | Buy |
+3
| New | +$27 | ﹤0.01% | 661 |
|
|
2023
Q4 | – | Sell |
-4
| Closed | -$22 | – | 699 |
|
|
2023
Q3 | $22 | Hold |
4
| – | – | ﹤0.01% | 651 |
|
|
2023
Q2 | $25 | Buy |
+4
| New | +$25 | ﹤0.01% | 672 |
|